Insider Buy/Sell Details for the Biotechnology Industry — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1179)
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,321
Price
$96.75
Total Value
$127.81K
Shares Held After
42,477
% of Holdings
3.0%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
189
Price
$98.40
Total Value
$18.60K
Shares Held After
65,888
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
1,369
Price
$97.33
Total Value
$133.24K
Shares Held After
66,077
% of Holdings
2.0%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
1,106
Price
$96.75
Total Value
$107.01K
Shares Held After
67,446
% of Holdings
1.6%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
3,111
Price
$6.04
Total Value
$18.79K
Shares Held After
757,500
% of Holdings
0.4%
PharmaCyte Biotech, Inc. (PMCB)
SCHECHTER JONATHAN — Director
Shares
20,000
Price
$0.79
Total Value
$15.81K
Shares Held After
172,500
% of Holdings
11.6%
PharmaCyte Biotech, Inc. (PMCB)
Silverman Joshua — Director
Shares
30,000
Price
$0.79
Total Value
$23.67K
Shares Held After
376,250
% of Holdings
8.0%
Axsome Therapeutics, Inc. (AXSM)
TABUTEAU HERRIOT — Director
Shares
29,450
Price
$172.33
Total Value
$5.08M
Shares Held After
7,229
% of Holdings
80.3%
AN2 Therapeutics, Inc. (ANTX)
Eizen Joshua M — Chief Operating Officer and Chief Legal Officer
Shares
6,931
Price
$1.01
Total Value
$7.01K
Shares Held After
152,499
% of Holdings
4.3%
AN2 Therapeutics, Inc. (ANTX)
Chanda Sanjay — Chief Development Officer
Shares
5,956
Price
$1.01
Total Value
$6.03K
Shares Held After
75,823
% of Holdings
7.3%
AN2 Therapeutics, Inc. (ANTX)
Prior Stephen David — Chief Strategy Officer
Shares
2,858
Price
$1.01
Total Value
$2.89K
Shares Held After
59,086
% of Holdings
4.6%
AN2 Therapeutics, Inc. (ANTX)
Day Lucy — Chief Financial Officer
Shares
5,512
Price
$1.01
Total Value
$5.58K
Shares Held After
75,363
% of Holdings
6.8%
Acumen Pharmaceuticals, Inc. (ABOS)
Barton Russell — Chief Operating Officer
Shares
3,618
Price
$1.97
Total Value
$7.11K
Shares Held After
128,499
% of Holdings
2.7%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
3,801
Price
$1.97
Total Value
$7.48K
Shares Held After
146,229
% of Holdings
2.5%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
7,097
Price
$1.97
Total Value
$13.96K
Shares Held After
150,030
% of Holdings
4.5%
Acumen Pharmaceuticals, Inc. (ABOS)
OConnell Daniel Joseph — Director
Shares
5,102
Price
$1.97
Total Value
$10.03K
Shares Held After
657,737
% of Holdings
0.8%
Acumen Pharmaceuticals, Inc. (ABOS)
Siemers Eric — Chief Medical Officer
Shares
6,834
Price
$1.97
Total Value
$13.44K
Shares Held After
159,464
% of Holdings
4.1%
Acumen Pharmaceuticals, Inc. (ABOS)
Zuga Matt — CFO & Chief Business Officer
Shares
5,100
Price
$1.97
Total Value
$10.03K
Shares Held After
222,644
% of Holdings
2.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
WAGNER CHARLES F JR — EVP, CO & FO
Shares
9,532
Price
$461.00
Total Value
$4.39M
Shares Held After
37,725
% of Holdings
20.2%
Maze Therapeutics, Inc. (MAZE)
Sohn Catherine A. — Director
Shares
2,493
Price
$38.62
Total Value
$96.27K
Shares Held After
0
% of Holdings
100.0%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
8,003
Price
$19.89
Total Value
$159.16K
Shares Held After
989,893
% of Holdings
0.8%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
54
Price
$76.95
Total Value
$4.16K
Shares Held After
6,902
% of Holdings
0.8%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
1,615
Price
$173.33
Total Value
$279.93K
Shares Held After
93,139
% of Holdings
1.7%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
957
Price
$175.01
Total Value
$167.48K
Shares Held After
94,754
% of Holdings
1.0%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
2,830
Price
$174.21
Total Value
$493.01K
Shares Held After
95,711
% of Holdings
2.9%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
4,783
Price
$173.47
Total Value
$829.71K
Shares Held After
98,541
% of Holdings
4.6%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
8,003
Price
$19.89
Total Value
$159.16K
Shares Held After
989,893
% of Holdings
0.8%
CRISPR Therapeutics AG (CRSP)
Prasad Raju — Chief Financial Officer
Shares
5,763
Price
$60.21
Total Value
$347.01K
Shares Held After
6,767
% of Holdings
46.0%
CRISPR Therapeutics AG (CRSP)
Prasad Raju — Chief Financial Officer
Shares
5,004
Price
$60.00
Total Value
$300.24K
Shares Held After
12,530
% of Holdings
28.5%
CRISPR Therapeutics AG (CRSP)
Prasad Raju — Chief Financial Officer
Shares
18,933
Price
$60.18
Total Value
$1.14M
Shares Held After
17,534
% of Holdings
51.9%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
20,000
Price
$35.18
Total Value
$703.66K
Shares Held After
1,235
% of Holdings
94.2%
PUMA BIOTECHNOLOGY, INC. (PBYI)
AUERBACH ALAN H — Director
Shares
16,938
Price
$5.84
Total Value
$98.99K
Shares Held After
7,163,963
% of Holdings
0.2%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
10,000
Price
$16.44
Total Value
$164.40K
Shares Held After
1,222,312
% of Holdings
0.8%
PUMA BIOTECHNOLOGY, INC. (PBYI)
HUNT DOUGLAS M — The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.
Shares
3,973
Price
$5.84
Total Value
$23.22K
Shares Held After
160,921
% of Holdings
2.4%
PUMA BIOTECHNOLOGY, INC. (PBYI)
NOUGUES MAXIMO F — Chief Financial Officer
Shares
4,540
Price
$5.84
Total Value
$26.53K
Shares Held After
199,689
% of Holdings
2.2%
PTC THERAPEUTICS, INC. (PTCT)
Golden Lee Scott — EVP & CHIEF MEDICAL OFFICER
Shares
1,340
Price
$76.95
Total Value
$103.11K
Shares Held After
93,936
% of Holdings
1.4%
PTC THERAPEUTICS, INC. (PTCT)
Pauwels Eric — CHIEF BUSINESS OFFICER
Shares
1,789
Price
$76.95
Total Value
$137.66K
Shares Held After
88,841
% of Holdings
2.0%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,739
Price
$76.95
Total Value
$133.82K
Shares Held After
119,162
% of Holdings
1.4%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
5,149
Price
$76.95
Total Value
$396.22K
Shares Held After
399,983
% of Holdings
1.3%
INSMED Inc (INSM)
Bonstein Sara — Chief Financial Officer
Shares
1,517
Price
$173.33
Total Value
$262.94K
Shares Held After
83,631
% of Holdings
1.8%
PTC THERAPEUTICS, INC. (PTCT)
Utter Christine Marie — SVP, CHIEF ACCOUNTING OFFICER
Shares
1,381
Price
$76.95
Total Value
$106.27K
Shares Held After
74,962
% of Holdings
1.8%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
1,279
Price
$76.95
Total Value
$98.42K
Shares Held After
117,103
% of Holdings
1.1%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
1,396
Price
$173.33
Total Value
$241.97K
Shares Held After
58,799
% of Holdings
2.3%
Surrozen, Inc./DE (SRZN)
COLUMN GROUP III GP, LP — 10% Owner
Shares
7,097
Price
$19.89
Total Value
$141.14K
Shares Held After
876,557
% of Holdings
0.8%
INSMED Inc (INSM)
Lewis William — Director
Shares
4,096
Price
$173.33
Total Value
$709.96K
Shares Held After
320,987
% of Holdings
1.3%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
7,097
Price
$19.89
Total Value
$141.14K
Shares Held After
876,557
% of Holdings
0.8%
PTC THERAPEUTICS, INC. (PTCT)
Gravier Pierre — CHIEF FINANCIAL OFFICER
Shares
2,139
Price
$76.95
Total Value
$164.60K
Shares Held After
90,310
% of Holdings
2.3%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
1,429
Price
$173.33
Total Value
$247.69K
Shares Held After
110,462
% of Holdings
1.3%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
220,000
Price
$4.36
Total Value
$959.20K
Shares Held After
6,649,863
% of Holdings
3.2%
Lyra Therapeutics, Inc. (LYRA)
Cavalier Jason — Chief Financial Officer
Shares
769
Price
$3.36
Total Value
$2.59K
Shares Held After
518,547
% of Holdings
0.1%
Showing 851–900 of 1179 transactions (page 18 of 24)